INTC
41
4
JNJ
41
3
AIZ
82
2
EOG
56
-2
FSLR
44
-2
HBI
58
3
CVX
43
-3
CCI
30
-11
STI
45
26
DLTR
38
-4
ETR
65
2
MSI
72
-3
CL
54
3
ROST
57
-3
MTCH
20
-8
VNO
46
-13
FMC
23
-3
PEP
39
-9
CB
57
2
AN
50
-5
INTC
41
4
JNJ
41
3
AIZ
82
2
EOG
56
-2
FSLR
44
-2
HBI
58
3
CVX
43
-3
CCI
30
-11
STI
45
26
DLTR
38
-4
ETR
65
2
MSI
72
-3
CL
54
3
ROST
57
-3
MTCH
20
-8
VNO
46
-13
FMC
23
-3
PEP
39
-9
CB
57
2
AN
50
-5
Financhill
Back

WAVE Life Sciences 10K Form

Sell
41

WVE
WAVE Life Sciences

Last Price:
13.66
Seasonality Move:
-7.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-09 10Q WVE/WAVE Life Sciences Quarterly
2023-08-03 10Q WVE/WAVE Life Sciences Quarterly
2023-05-03 10Q WVE/WAVE Life Sciences Quarterly
2022-11-10 10Q WVE/WAVE Life Sciences Quarterly
2022-08-11 10Q WVE/WAVE Life Sciences Quarterly
2022-05-12 10Q WVE/WAVE Life Sciences Quarterly

Receive WVE News And Ratings

See the #1 stock for the next 7 days that we like better than WVE

WVE Financial Statistics

Sales & Book Value

Annual Sales: $113.31M
Cash Flow: $-27.52M
Price / Cash Flow: 0
Annual Sales: $-0.03
Price / Book: 0

Profitability

EPS (TTM): -0.57000
Net Income (TTM): $-73.49M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: -31.98%

WAVE Life Sciences Earnings Forecast

Key WAVE Life Sciences Financial Ratios

  • The Selling, General & Administrative Expenses for WVE have been equal to 45.27% of Gross Profit Margin.
  • The Research & Development expenses have been 114.74% of Revenue.
  • The Net Earning history of WVE is -50.76% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

WAVE Life Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: WVE
CUSIP: Y95308
Website: wavelifesciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.99
Quick Ratio: 0.9

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

WVE Technical Analysis vs Fundamental Analysis

Sell
41
WAVE Life Sciences (WVE) is a Sell

Is WAVE Life Sciences a Buy or a Sell?

  • WAVE Life Sciences stock is rated a Sell
    The current WAVE Life Sciences [WVE] share price is $13.67. The Score for WVE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.